An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation

NCT00403767 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

14269

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation
Stroke
Embolism

Interventions

DRUG: Rivaroxaban
DRUG: Warfarin
DRUG: Matching placebo for Rivaroxaban arm (Warfarin placebo)
DRUG: Matching placebo for Warfarin arm (Rivaroxaban placebo)

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Collaborators

[object Object]